China
· Delayed Price · Currency is CNY Bloomage BioTechnology Corporation Statistics
Total Valuation
Bloomage BioTechnology Corporation has a market cap or net worth of CNY 28.75 billion. The enterprise value is 28.54 billion.
| Market Cap | 28.75B |
| Enterprise Value | 28.54B |
Important Dates
The last earnings date was Friday, October 25, 2024.
| Earnings Date | Oct 25, 2024 |
| Ex-Dividend Date | Aug 8, 2024 |
Share Statistics
Bloomage BioTechnology Corporation has 478.36 million shares outstanding. The number of shares has decreased by -0.01% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 478.36M |
| Shares Change (YoY) | -0.01% |
| Shares Change (QoQ) | -0.03% |
| Owned by Insiders (%) | 0.72% |
| Owned by Institutions (%) | 11.37% |
| Float | 154.45M |
Valuation Ratios
The trailing PE ratio is 65.98 and the forward PE ratio is 40.96.
| PE Ratio | 65.98 |
| Forward PE | 40.96 |
| PS Ratio | 5.07 |
| PB Ratio | 4.10 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 39.42, with an EV/FCF ratio of -239.89.
| EV / Earnings | 64.85 |
| EV / Sales | 4.98 |
| EV / EBITDA | 39.42 |
| EV / EBIT | 65.71 |
| EV / FCF | -239.89 |
Financial Position
The company has a current ratio of 2.36, with a Debt / Equity ratio of 0.04.
| Current Ratio | 2.36 |
| Quick Ratio | 0.99 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.42 |
| Debt / FCF | -2.54 |
| Interest Coverage | 59.86 |
Financial Efficiency
Return on equity (ROE) is 6.20% and return on invested capital (ROIC) is 3.74%.
| Return on Equity (ROE) | 6.20% |
| Return on Assets (ROA) | 3.19% |
| Return on Capital (ROIC) | 3.74% |
| Revenue Per Employee | 1.23M |
| Profits Per Employee | 94,560 |
| Employee Count | 4,655 |
| Asset Turnover | 0.67 |
| Inventory Turnover | 1.22 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -22.67% in the last 52 weeks. The beta is 0.84, so Bloomage BioTechnology Corporation's price volatility has been lower than the market average.
| Beta (5Y) | 0.84 |
| 52-Week Price Change | -22.67% |
| 50-Day Moving Average | 57.83 |
| 200-Day Moving Average | 58.84 |
| Relative Strength Index (RSI) | 47.92 |
| Average Volume (20 Days) | 5,713,182 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Bloomage BioTechnology Corporation had revenue of CNY 5.73 billion and earned 440.18 million in profits. Earnings per share was 0.91.
| Revenue | 5.73B |
| Gross Profit | 4.20B |
| Operating Income | 434.40M |
| Pretax Income | 527.86M |
| Net Income | 440.18M |
| EBITDA | 664.83M |
| EBIT | 434.40M |
| Earnings Per Share (EPS) | 0.91 |
Balance Sheet
The company has 541.55 million in cash and 302.03 million in debt, giving a net cash position of 239.52 million or 0.50 per share.
| Cash & Cash Equivalents | 541.55M |
| Total Debt | 302.03M |
| Net Cash | 239.52M |
| Net Cash Per Share | 0.50 |
| Equity (Book Value) | 7.05B |
| Book Value Per Share | 14.67 |
| Working Capital | 1.55B |
Cash Flow
In the last 12 months, operating cash flow was 738.82 million and capital expenditures -857.81 million, giving a free cash flow of -118.99 million.
| Operating Cash Flow | 738.82M |
| Capital Expenditures | -857.81M |
| Free Cash Flow | -118.99M |
| FCF Per Share | -0.25 |
Margins
Gross margin is 73.25%, with operating and profit margins of 7.58% and 7.68%.
| Gross Margin | 73.25% |
| Operating Margin | 7.58% |
| Pretax Margin | 9.21% |
| Profit Margin | 7.68% |
| EBITDA Margin | 11.60% |
| EBIT Margin | 7.58% |
| FCF Margin | -2.08% |
Dividends & Yields
This stock pays an annual dividend of 0.38, which amounts to a dividend yield of 0.62%.
| Dividend Per Share | 0.38 |
| Dividend Yield | 0.62% |
| Dividend Growth (YoY) | -37.70% |
| Years of Dividend Growth | 4 |
| Payout Ratio | 41.94% |
| Buyback Yield | 0.01% |
| Shareholder Yield | 0.63% |
| Earnings Yield | 1.52% |
| FCF Yield | -0.41% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Bloomage BioTechnology Corporation has an Altman Z-Score of 12.53.
| Altman Z-Score | 12.53 |
| Piotroski F-Score | n/a |